Literature DB >> 32932287

Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania.

Rūta Everatt1, Irena Kuzmickienė1, Birutė Intaitė2, Ahti Anttila3.   

Abstract

The cervical cancer burden in Lithuania has remained high, and there are no previous effectiveness studies of cervical cancer prevention programme in the country. We investigated the effect of a prevention programme on the risk of mortality from cervical cancer in Lithuania by conducting a mortality audit study. The register-based case-control study included 715 cervical cancer deaths that occurred during 2010-2015 in Lithuania and their 2145 matched controls. Screening histories for cases and controls were obtained from the National Health Insurance Fund database. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression and corrected for self-selection bias. Index screening was associated with a 56% reduction in the cervical cancer death risk, OR: 0.44; 95% CI 0.26-0.74. The ORs for stage I and stage II+ cancers were 0.80; 95% CI 0.32-2.00 and 0.36; 95% CI 0.21-0.62, respectively. The preventive effect was statistically significant for women aged ≥40 years, while nonsignificant for younger. In women who died of cervical cancer, 71% were not invited and 88% were not screened within the recommended 36 months prior to index date. Among cases with index invitation, 32% had index screening compared to 70% in controls. In conclusion, participation in screening has been effective in reducing cervical cancer mortality in Lithuania. The study shows poor screening attendance, emphasizing the importance of greater efforts at the national level to improve the effectiveness of the screening.

Entities:  

Year:  2020        PMID: 32932287     DOI: 10.1097/CEJ.0000000000000603

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  1 in total

1.  An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020.

Authors:  Rūta Everatt; Daiva Gudavičienė
Journal:  BMC Public Health       Date:  2022-09-23       Impact factor: 4.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.